Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 1,341–1,350 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 1341

    Medicine slug
    risperidone
    Compared field
    bioavailability
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    73
    Source count
    68
    Agreement rate
    0.985294
    Recorded readings

    1. 70%

      Numeric value
      70
      Unit
      %
      Source records
      67

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 67 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390904c2-fcfa-466e-e063-6394a90a03af (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda104ac-1eea-4a1a-836a-24bcc034b90f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b611fe52-1787-47e6-8a6b-1999a4e4f22c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aab773b2-a605-4cf8-a301-57e390fe67a6 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f83d3e9-04ab-4b24-ad1f-7ed2e784298a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cc027f0-3462-4a2f-925b-d8a529bcb3c3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0a21bec-68f0-444e-a611-d0602859410c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4604052d-dbda-4535-b7b8-1bd72a129aca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91f551e-926f-440d-83d2-357e9d7484fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cf6fd-9932-47fc-8736-476cc53a13fa (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:420cfeef-0061-43b9-9491-dbd6ad866e55 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e422ec-da66-41b0-83c1-aefd940beda0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84807bd-35d7-4138-8989-42617d69293a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6347895-5f16-43b4-92a0-b9904ac81937 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdb08381-dbfc-442e-8d3c-22d3a0f2f6c5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a4158fe-37d4-4c97-9c44-1c3489fe2a9f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:701e1cd8-2868-4d29-85a9-a2212c88165f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:856d65dc-f330-4195-b271-d0bdbe99519d (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:088dc3dd-7740-471b-8c06-5a47900ae5b5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79648a52-1364-c25b-e053-2a91aa0a8ea4 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d9519af-5a5e-47ce-8a0f-9b9cfac00e19 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e90c886c-132a-4df6-8604-cfe5ffa49d5b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f9ea0cc-b86b-a11f-e063-6294a90a9620 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39d41b28-93eb-446b-9652-7432858ccbab (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:684dcda4-d270-400c-9798-7d920a038bbb (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e35be034-6275-41fb-bec4-9ae451458701 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12a479c4-a84a-4308-b89f-be0315826fd5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f47ec91-602f-4fba-8f7e-a5698760b655 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f3ebec-a742-48fc-e063-6394a90a1452 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4c51e2-b09b-9fd0-e063-6294a90ae699 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:523d4f99-1d6f-413f-9d6e-2ca430aaac14 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5c9889-4dc3-48df-8629-4ac099e2b4c0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5abd75f-7f4a-4a7d-b849-82fce88f5ff7 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ce21196-4aa0-469b-8f04-6650b2c48cb5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6767972-2d3f-482b-80bd-ac93e28fdd05 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac152803-d75f-4c3c-bc49-8663b21a3a82 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66390528-7517-452a-ae76-4338ec7db3ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:448467a3-44ef-c87b-e063-6294a90a5ec9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:095630bd-a77e-434e-94ee-f13da445d8f2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee7d6779-7421-4761-99d2-ccbfde9385a8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03d3b52d-3a7d-4595-84c9-332da6ca9171 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc8c6638-f487-49df-a265-78caa93e43d8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV = 25%).
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee495f20-c668-4d8f-9684-1029a4f232db (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58b7504f-c4a3-ef1b-e063-6394a90ac0f3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e117c7e-02fc-4343-92a1-230061dfc5e0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43aa2a4f-1123-4f86-800b-9218882f7bcd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d43bf6-a695-453a-a5c7-9581effe585c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3261e8cf-cc6e-4011-9246-aee623ad8971 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f11dae15-b057-4258-9229-3819d0c980fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbc37f1-6d6a-4021-8976-1f103ce1cfbd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:101b2d4d-4740-4225-94bc-aecc05d82c6b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52bb35ac-1f7d-bfbe-e063-6294a90aa2b9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b784f21-fc02-6542-e063-6294a90a285e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:713b5ac7-53d6-4139-8599-3028f789de4b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:339ec0af-c0f0-4115-8cdb-8f052e633f47 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc55f60a-8121-44bb-bdfc-1d311879ba4f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50216d94-7667-bd6a-e063-6394a90a8155 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca41c144-224a-4d57-88d7-8778e6c69ed2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be388943-fe0c-4c82-ac8e-3df9f77b2891 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:394c7e27-52a2-4d4c-8c6e-fe37b03266ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4582bdf-5eda-438c-98b4-0517500501e8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:739dcf8a-ed73-5eb0-899b-7e51cb73c335 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2776a647-678d-465c-9db3-4a9459ce779e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e72a2768-815f-47bf-b2f9-16a93dd10684 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5643c32b-310e-4888-e063-6394a90ab62f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0ef6df3-67e5-47b1-bcf7-f67aa030caca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The absolute oral bioavailability of risperidone is 70% (CV=25%).

    2. 64%

      Numeric value
      64
      Unit
      %
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:734eb776-4be0-4808-834b-0d8b0f9e021e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Cimetidine and ranitidine increased the bioavailability of oral risperidone by 64% and 26%, respectively.

  2. Projected row 1342

    Medicine slug
    risperidone
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    73
    Source count
    69
    Agreement rate
    0.971014
    Recorded readings

    1. 3 hours

      Numeric value
      3
      Unit
      hours
      Source records
      67

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 67 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390904c2-fcfa-466e-e063-6394a90a03af (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda104ac-1eea-4a1a-836a-24bcc034b90f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b611fe52-1787-47e6-8a6b-1999a4e4f22c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aab773b2-a605-4cf8-a301-57e390fe67a6 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f83d3e9-04ab-4b24-ad1f-7ed2e784298a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cc027f0-3462-4a2f-925b-d8a529bcb3c3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0a21bec-68f0-444e-a611-d0602859410c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4604052d-dbda-4535-b7b8-1bd72a129aca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91f551e-926f-440d-83d2-357e9d7484fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cf6fd-9932-47fc-8736-476cc53a13fa (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:420cfeef-0061-43b9-9491-dbd6ad866e55 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e422ec-da66-41b0-83c1-aefd940beda0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84807bd-35d7-4138-8989-42617d69293a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6347895-5f16-43b4-92a0-b9904ac81937 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdb08381-dbfc-442e-8d3c-22d3a0f2f6c5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a4158fe-37d4-4c97-9c44-1c3489fe2a9f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:701e1cd8-2868-4d29-85a9-a2212c88165f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:856d65dc-f330-4195-b271-d0bdbe99519d (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:088dc3dd-7740-471b-8c06-5a47900ae5b5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79648a52-1364-c25b-e053-2a91aa0a8ea4 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d9519af-5a5e-47ce-8a0f-9b9cfac00e19 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e90c886c-132a-4df6-8604-cfe5ffa49d5b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f9ea0cc-b86b-a11f-e063-6294a90a9620 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39d41b28-93eb-446b-9652-7432858ccbab (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:684dcda4-d270-400c-9798-7d920a038bbb (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e35be034-6275-41fb-bec4-9ae451458701 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12a479c4-a84a-4308-b89f-be0315826fd5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f47ec91-602f-4fba-8f7e-a5698760b655 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f3ebec-a742-48fc-e063-6394a90a1452 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4c51e2-b09b-9fd0-e063-6294a90ae699 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:523d4f99-1d6f-413f-9d6e-2ca430aaac14 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5c9889-4dc3-48df-8629-4ac099e2b4c0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5abd75f-7f4a-4a7d-b849-82fce88f5ff7 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ce21196-4aa0-469b-8f04-6650b2c48cb5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6767972-2d3f-482b-80bd-ac93e28fdd05 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac152803-d75f-4c3c-bc49-8663b21a3a82 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66390528-7517-452a-ae76-4338ec7db3ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:448467a3-44ef-c87b-e063-6294a90a5ec9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:095630bd-a77e-434e-94ee-f13da445d8f2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee7d6779-7421-4761-99d2-ccbfde9385a8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03d3b52d-3a7d-4595-84c9-332da6ca9171 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc8c6638-f487-49df-a265-78caa93e43d8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV = 30%) in extensive metabolizers and 20 hours (CV = 40%) in poor metabolizers.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee495f20-c668-4d8f-9684-1029a4f232db (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58b7504f-c4a3-ef1b-e063-6394a90ac0f3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e117c7e-02fc-4343-92a1-230061dfc5e0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43aa2a4f-1123-4f86-800b-9218882f7bcd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d43bf6-a695-453a-a5c7-9581effe585c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3261e8cf-cc6e-4011-9246-aee623ad8971 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f11dae15-b057-4258-9229-3819d0c980fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbc37f1-6d6a-4021-8976-1f103ce1cfbd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:101b2d4d-4740-4225-94bc-aecc05d82c6b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52bb35ac-1f7d-bfbe-e063-6294a90aa2b9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b784f21-fc02-6542-e063-6294a90a285e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:713b5ac7-53d6-4139-8599-3028f789de4b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:339ec0af-c0f0-4115-8cdb-8f052e633f47 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc55f60a-8121-44bb-bdfc-1d311879ba4f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50216d94-7667-bd6a-e063-6394a90a8155 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca41c144-224a-4d57-88d7-8778e6c69ed2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be388943-fe0c-4c82-ac8e-3df9f77b2891 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:394c7e27-52a2-4d4c-8c6e-fe37b03266ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4582bdf-5eda-438c-98b4-0517500501e8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:739dcf8a-ed73-5eb0-899b-7e51cb73c335 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2776a647-678d-465c-9db3-4a9459ce779e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e72a2768-815f-47bf-b2f9-16a93dd10684 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5643c32b-310e-4888-e063-6394a90ab62f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0ef6df3-67e5-47b1-bcf7-f67aa030caca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.

    2. 14 to 22 days

      Numeric value
      Not parsed
      Unit
      Not recorded
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:734eb776-4be0-4808-834b-0d8b0f9e021e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The mean apparent half-life (t1/2) of UZEDY ranges between 14 to 22 days for risperidone, 9-hydroxyrisperidone, and risperidone and 9-hydroxyrisperidone combined.

    3. 3 to 6 days

      Numeric value
      Not parsed
      Unit
      Not recorded
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d526af85-ee70-4657-a27e-d451027ffd9e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        This half-life of 3 to 6 days is related to the erosion of the microspheres and subsequent absorption of risperidone.

  3. Projected row 1343

    Medicine slug
    risperidone
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    73
    Source count
    69
    Agreement rate
    1
    Recorded readings

    1. 90%

      Numeric value
      90
      Unit
      %
      Source records
      69

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 69 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390904c2-fcfa-466e-e063-6394a90a03af (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda104ac-1eea-4a1a-836a-24bcc034b90f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b611fe52-1787-47e6-8a6b-1999a4e4f22c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aab773b2-a605-4cf8-a301-57e390fe67a6 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f83d3e9-04ab-4b24-ad1f-7ed2e784298a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cc027f0-3462-4a2f-925b-d8a529bcb3c3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0a21bec-68f0-444e-a611-d0602859410c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4604052d-dbda-4535-b7b8-1bd72a129aca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91f551e-926f-440d-83d2-357e9d7484fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cf6fd-9932-47fc-8736-476cc53a13fa (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:420cfeef-0061-43b9-9491-dbd6ad866e55 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e422ec-da66-41b0-83c1-aefd940beda0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84807bd-35d7-4138-8989-42617d69293a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6347895-5f16-43b4-92a0-b9904ac81937 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdb08381-dbfc-442e-8d3c-22d3a0f2f6c5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a4158fe-37d4-4c97-9c44-1c3489fe2a9f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:701e1cd8-2868-4d29-85a9-a2212c88165f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:856d65dc-f330-4195-b271-d0bdbe99519d (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:088dc3dd-7740-471b-8c06-5a47900ae5b5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79648a52-1364-c25b-e053-2a91aa0a8ea4 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d9519af-5a5e-47ce-8a0f-9b9cfac00e19 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e90c886c-132a-4df6-8604-cfe5ffa49d5b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f9ea0cc-b86b-a11f-e063-6294a90a9620 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39d41b28-93eb-446b-9652-7432858ccbab (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:684dcda4-d270-400c-9798-7d920a038bbb (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e35be034-6275-41fb-bec4-9ae451458701 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12a479c4-a84a-4308-b89f-be0315826fd5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:734eb776-4be0-4808-834b-0d8b0f9e021e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f47ec91-602f-4fba-8f7e-a5698760b655 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f3ebec-a742-48fc-e063-6394a90a1452 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4c51e2-b09b-9fd0-e063-6294a90ae699 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:523d4f99-1d6f-413f-9d6e-2ca430aaac14 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5c9889-4dc3-48df-8629-4ac099e2b4c0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5abd75f-7f4a-4a7d-b849-82fce88f5ff7 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ce21196-4aa0-469b-8f04-6650b2c48cb5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6767972-2d3f-482b-80bd-ac93e28fdd05 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac152803-d75f-4c3c-bc49-8663b21a3a82 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66390528-7517-452a-ae76-4338ec7db3ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:448467a3-44ef-c87b-e063-6294a90a5ec9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:095630bd-a77e-434e-94ee-f13da445d8f2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee7d6779-7421-4761-99d2-ccbfde9385a8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03d3b52d-3a7d-4595-84c9-332da6ca9171 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc8c6638-f487-49df-a265-78caa93e43d8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee495f20-c668-4d8f-9684-1029a4f232db (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58b7504f-c4a3-ef1b-e063-6394a90ac0f3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e117c7e-02fc-4343-92a1-230061dfc5e0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43aa2a4f-1123-4f86-800b-9218882f7bcd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d43bf6-a695-453a-a5c7-9581effe585c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3261e8cf-cc6e-4011-9246-aee623ad8971 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f11dae15-b057-4258-9229-3819d0c980fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbc37f1-6d6a-4021-8976-1f103ce1cfbd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:101b2d4d-4740-4225-94bc-aecc05d82c6b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52bb35ac-1f7d-bfbe-e063-6294a90aa2b9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b784f21-fc02-6542-e063-6294a90a285e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:713b5ac7-53d6-4139-8599-3028f789de4b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:339ec0af-c0f0-4115-8cdb-8f052e633f47 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc55f60a-8121-44bb-bdfc-1d311879ba4f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d526af85-ee70-4657-a27e-d451027ffd9e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90% and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50216d94-7667-bd6a-e063-6394a90a8155 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca41c144-224a-4d57-88d7-8778e6c69ed2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be388943-fe0c-4c82-ac8e-3df9f77b2891 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:394c7e27-52a2-4d4c-8c6e-fe37b03266ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4582bdf-5eda-438c-98b4-0517500501e8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:739dcf8a-ed73-5eb0-899b-7e51cb73c335 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2776a647-678d-465c-9db3-4a9459ce779e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e72a2768-815f-47bf-b2f9-16a93dd10684 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5643c32b-310e-4888-e063-6394a90ab62f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0ef6df3-67e5-47b1-bcf7-f67aa030caca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The plasma protein binding of risperidone is approximately 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%.

  4. Projected row 1344

    Medicine slug
    risperidone
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    73
    Source count
    67
    Agreement rate
    1
    Recorded readings

    1. 1 hour

      Numeric value
      1
      Unit
      hours
      Source records
      67

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 67 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390904c2-fcfa-466e-e063-6394a90a03af (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda104ac-1eea-4a1a-836a-24bcc034b90f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b611fe52-1787-47e6-8a6b-1999a4e4f22c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aab773b2-a605-4cf8-a301-57e390fe67a6 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f83d3e9-04ab-4b24-ad1f-7ed2e784298a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cc027f0-3462-4a2f-925b-d8a529bcb3c3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0a21bec-68f0-444e-a611-d0602859410c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4604052d-dbda-4535-b7b8-1bd72a129aca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91f551e-926f-440d-83d2-357e9d7484fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cf6fd-9932-47fc-8736-476cc53a13fa (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:420cfeef-0061-43b9-9491-dbd6ad866e55 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e422ec-da66-41b0-83c1-aefd940beda0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84807bd-35d7-4138-8989-42617d69293a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6347895-5f16-43b4-92a0-b9904ac81937 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdb08381-dbfc-442e-8d3c-22d3a0f2f6c5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a4158fe-37d4-4c97-9c44-1c3489fe2a9f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:701e1cd8-2868-4d29-85a9-a2212c88165f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:856d65dc-f330-4195-b271-d0bdbe99519d (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:088dc3dd-7740-471b-8c06-5a47900ae5b5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79648a52-1364-c25b-e053-2a91aa0a8ea4 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d9519af-5a5e-47ce-8a0f-9b9cfac00e19 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e90c886c-132a-4df6-8604-cfe5ffa49d5b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f9ea0cc-b86b-a11f-e063-6294a90a9620 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39d41b28-93eb-446b-9652-7432858ccbab (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:684dcda4-d270-400c-9798-7d920a038bbb (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e35be034-6275-41fb-bec4-9ae451458701 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12a479c4-a84a-4308-b89f-be0315826fd5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f47ec91-602f-4fba-8f7e-a5698760b655 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f3ebec-a742-48fc-e063-6394a90a1452 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4c51e2-b09b-9fd0-e063-6294a90ae699 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:523d4f99-1d6f-413f-9d6e-2ca430aaac14 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5c9889-4dc3-48df-8629-4ac099e2b4c0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5abd75f-7f4a-4a7d-b849-82fce88f5ff7 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ce21196-4aa0-469b-8f04-6650b2c48cb5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6767972-2d3f-482b-80bd-ac93e28fdd05 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac152803-d75f-4c3c-bc49-8663b21a3a82 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66390528-7517-452a-ae76-4338ec7db3ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:448467a3-44ef-c87b-e063-6294a90a5ec9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:095630bd-a77e-434e-94ee-f13da445d8f2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee7d6779-7421-4761-99d2-ccbfde9385a8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03d3b52d-3a7d-4595-84c9-332da6ca9171 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc8c6638-f487-49df-a265-78caa93e43d8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee495f20-c668-4d8f-9684-1029a4f232db (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58b7504f-c4a3-ef1b-e063-6394a90ac0f3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e117c7e-02fc-4343-92a1-230061dfc5e0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43aa2a4f-1123-4f86-800b-9218882f7bcd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d43bf6-a695-453a-a5c7-9581effe585c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3261e8cf-cc6e-4011-9246-aee623ad8971 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f11dae15-b057-4258-9229-3819d0c980fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbc37f1-6d6a-4021-8976-1f103ce1cfbd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:101b2d4d-4740-4225-94bc-aecc05d82c6b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52bb35ac-1f7d-bfbe-e063-6294a90aa2b9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b784f21-fc02-6542-e063-6294a90a285e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:713b5ac7-53d6-4139-8599-3028f789de4b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:339ec0af-c0f0-4115-8cdb-8f052e633f47 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc55f60a-8121-44bb-bdfc-1d311879ba4f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50216d94-7667-bd6a-e063-6394a90a8155 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca41c144-224a-4d57-88d7-8778e6c69ed2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be388943-fe0c-4c82-ac8e-3df9f77b2891 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:394c7e27-52a2-4d4c-8c6e-fe37b03266ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4582bdf-5eda-438c-98b4-0517500501e8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:739dcf8a-ed73-5eb0-899b-7e51cb73c335 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2776a647-678d-465c-9db3-4a9459ce779e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e72a2768-815f-47bf-b2f9-16a93dd10684 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5643c32b-310e-4888-e063-6394a90ab62f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0ef6df3-67e5-47b1-bcf7-f67aa030caca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour.

  5. Projected row 1345

    Medicine slug
    risperidone
    Compared field
    volumeOfDistribution
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    73
    Source count
    69
    Agreement rate
    0.985507
    Recorded readings

    1. 1-2 L/kg

      Numeric value
      1
      Unit
      L/kg
      Source records
      68

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 68 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:390904c2-fcfa-466e-e063-6394a90a03af (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda104ac-1eea-4a1a-836a-24bcc034b90f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b611fe52-1787-47e6-8a6b-1999a4e4f22c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aab773b2-a605-4cf8-a301-57e390fe67a6 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f83d3e9-04ab-4b24-ad1f-7ed2e784298a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cc027f0-3462-4a2f-925b-d8a529bcb3c3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0a21bec-68f0-444e-a611-d0602859410c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4604052d-dbda-4535-b7b8-1bd72a129aca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91f551e-926f-440d-83d2-357e9d7484fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab1cf6fd-9932-47fc-8736-476cc53a13fa (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:420cfeef-0061-43b9-9491-dbd6ad866e55 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e422ec-da66-41b0-83c1-aefd940beda0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c84807bd-35d7-4138-8989-42617d69293a (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6347895-5f16-43b4-92a0-b9904ac81937 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdb08381-dbfc-442e-8d3c-22d3a0f2f6c5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a4158fe-37d4-4c97-9c44-1c3489fe2a9f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:701e1cd8-2868-4d29-85a9-a2212c88165f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:856d65dc-f330-4195-b271-d0bdbe99519d (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:088dc3dd-7740-471b-8c06-5a47900ae5b5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79648a52-1364-c25b-e053-2a91aa0a8ea4 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d9519af-5a5e-47ce-8a0f-9b9cfac00e19 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e90c886c-132a-4df6-8604-cfe5ffa49d5b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f9ea0cc-b86b-a11f-e063-6294a90a9620 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39d41b28-93eb-446b-9652-7432858ccbab (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:684dcda4-d270-400c-9798-7d920a038bbb (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e35be034-6275-41fb-bec4-9ae451458701 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12a479c4-a84a-4308-b89f-be0315826fd5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:734eb776-4be0-4808-834b-0d8b0f9e021e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f47ec91-602f-4fba-8f7e-a5698760b655 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f3ebec-a742-48fc-e063-6394a90a1452 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4c51e2-b09b-9fd0-e063-6294a90ae699 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:523d4f99-1d6f-413f-9d6e-2ca430aaac14 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b5c9889-4dc3-48df-8629-4ac099e2b4c0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5abd75f-7f4a-4a7d-b849-82fce88f5ff7 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ce21196-4aa0-469b-8f04-6650b2c48cb5 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6767972-2d3f-482b-80bd-ac93e28fdd05 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac152803-d75f-4c3c-bc49-8663b21a3a82 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66390528-7517-452a-ae76-4338ec7db3ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:448467a3-44ef-c87b-e063-6294a90a5ec9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:095630bd-a77e-434e-94ee-f13da445d8f2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee7d6779-7421-4761-99d2-ccbfde9385a8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03d3b52d-3a7d-4595-84c9-332da6ca9171 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc8c6638-f487-49df-a265-78caa93e43d8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee495f20-c668-4d8f-9684-1029a4f232db (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58b7504f-c4a3-ef1b-e063-6394a90ac0f3 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e117c7e-02fc-4343-92a1-230061dfc5e0 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43aa2a4f-1123-4f86-800b-9218882f7bcd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d43bf6-a695-453a-a5c7-9581effe585c (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3261e8cf-cc6e-4011-9246-aee623ad8971 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f11dae15-b057-4258-9229-3819d0c980fe (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbc37f1-6d6a-4021-8976-1f103ce1cfbd (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1–2 L/kg.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:101b2d4d-4740-4225-94bc-aecc05d82c6b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52bb35ac-1f7d-bfbe-e063-6294a90aa2b9 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b784f21-fc02-6542-e063-6294a90a285e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:713b5ac7-53d6-4139-8599-3028f789de4b (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:339ec0af-c0f0-4115-8cdb-8f052e633f47 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc55f60a-8121-44bb-bdfc-1d311879ba4f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50216d94-7667-bd6a-e063-6394a90a8155 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca41c144-224a-4d57-88d7-8778e6c69ed2 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be388943-fe0c-4c82-ac8e-3df9f77b2891 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:394c7e27-52a2-4d4c-8c6e-fe37b03266ae (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4582bdf-5eda-438c-98b4-0517500501e8 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:739dcf8a-ed73-5eb0-899b-7e51cb73c335 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2776a647-678d-465c-9db3-4a9459ce779e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e72a2768-815f-47bf-b2f9-16a93dd10684 (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5643c32b-310e-4888-e063-6394a90ab62f (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1-2 L/kg.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0ef6df3-67e5-47b1-bcf7-f67aa030caca (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 to 2 L/kg.

    2. 1 L/kg

      Numeric value
      1
      Unit
      L/kg
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d526af85-ee70-4657-a27e-d451027ffd9e (opens source in a new tab)

        Risperidone label

        Version not recorded · Effective date not recorded

        The volume of distribution is 1 L/kg to 2 L/kg.

  6. Projected row 1346

    Medicine slug
    ritlecitinib
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 64%

      Numeric value
      64
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1882f799-61b0-4813-965a-4910c4ae419c (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Absorption The ritlecitinib absolute oral bioavailability is approximately 64%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b2f9446-fb23-4741-b73a-5a2f993733c3 (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Absorption The ritlecitinib absolute oral bioavailability is approximately 64%.

  7. Projected row 1347

    Medicine slug
    ritlecitinib
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 1.3 to 2.3 hours

      Numeric value
      1.3
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1882f799-61b0-4813-965a-4910c4ae419c (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Elimination The ritlecitinib mean terminal half-life ranges from 1.3 to 2.3 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b2f9446-fb23-4741-b73a-5a2f993733c3 (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Elimination The ritlecitinib mean terminal half-life ranges from 1.3 to 2.3 hours.

  8. Projected row 1348

    Medicine slug
    ritlecitinib
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 1 hour

      Numeric value
      1
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1882f799-61b0-4813-965a-4910c4ae419c (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Ritlecitinib peak plasma concentrations were reached within 1 hour following an oral dose.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b2f9446-fb23-4741-b73a-5a2f993733c3 (opens source in a new tab)

        Ritlecitinib label

        Version not recorded · Effective date not recorded

        Ritlecitinib peak plasma concentrations were reached within 1 hour following an oral dose.

  9. Projected row 1349

    Medicine slug
    ritonavir
    Compared field
    tMax
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    8
    Source count
    8
    Agreement rate
    0.75
    Recorded readings

    1. 2 hours

      Numeric value
      2
      Unit
      hours
      Source records
      6

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 6 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:11f757f1-cf48-47a8-925e-918359cbd2d4 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db633374-6d8e-4622-9fe1-f9d68baa59bb (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19503bc4-3443-4ad4-aa27-437f4f3288b1 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f92f1e2-59f4-f6c4-e063-6294a90a487b (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d2f8c6ba-5e06-4b03-8ca5-b4fd7e5a8925 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c811e3e-f685-4af7-a4d1-037f2613ee68 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 600 mg dose of oral solution, peak concentrations of ritonavir were achieved approximately 2 hours and 4 hours after dosing under fasting and non-fasting (514 KCal; 9% fat, 12% protein, and 79% carbohydrate) conditions, respectively.

    2. 3 hours

      Numeric value
      3
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2849298e-de6e-47bb-8194-56e075b33fc3 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 100 mg tablet dose of NORVIR, peak concentrations of ritonavir were achieved approximately 3 hours and 4 hours after dosing under fasting conditions and moderate-fat (857 KCal; 31% fat, 13% protein, and 56% carbohydrate) meal, respectively.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a32cb2e3-d4e5-4bbf-9d88-20b2b249e779 (opens source in a new tab)

        Ritonavir label

        Version not recorded · Effective date not recorded

        After a 100 mg tablet dose of ritonavir, peak concentrations of ritonavir were achieved approximately 3 hours and 4 hours after dosing under fasting conditions and moderate-fat (857 KCal; 31% fat, 13% protein, and 56% carbohydrate) meal, respectively.

  10. Projected row 1350

    Medicine slug
    rivaroxaban
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    26
    Source count
    18
    Agreement rate
    1
    Recorded readings

    1. 66%

      Numeric value
      66
      Unit
      %
      Source records
      18

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 18 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e8e4275c-6cbe-4976-8cae-f62baf954d27 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:65727928-9421-4df8-bff2-f72a9cc78069 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5524f30f-789d-4f5c-8f7c-d03a475b6d34 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e9ab975-db2f-423c-a089-bc5a73313609 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2f55475-2a98-43f3-9eac-93995904ebc5 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban Tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e76bf2cf-a8b8-4471-a8ce-57c918b11a48 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e95389b-0a93-4560-98c5-02637fb2600f (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:702fed3e-ae25-49ba-98cc-562e0e244214 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66 %.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:122e6f78-067b-9065-adb2-ec7fec9f008e (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg, administered in the fasted state has an absolute bioavailability of approximately 66%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0e105f6-28f3-45ee-83bd-7d458835242b (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9178947d-9d58-4c1a-b158-6030e17556af (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b53cebf-946c-b82b-e063-6394a90a5da7 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban Tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f0ef9361-f06d-4028-97af-183b545f4aea (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:38b11f5d-f0fc-46dc-aef1-ea31872bb621 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9fee7136-c8fd-4bea-ab15-7a0e7292396d (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10db92f9-2300-4a80-836b-673e1ae91610 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        XARELTO 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e62f23c6-89f2-4179-95dc-5732401b3f93 (opens source in a new tab)

        Rivaroxaban label

        Version not recorded · Effective date not recorded

        Rivaroxaban tablets 20 mg administered in the fasted state has an absolute bioavailability of approximately 66%.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=1340

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy